Renovascular Protective Effects of Erythropoietin in Patients with Chronic Kidney Disease
Author:
Affiliation:
1. Department of Cardiovascular Medicine, Saga University, Japan
2. Division of Nephrology, Department of Internal Medicine, Shinmatsudo Central General Hospital, Japan
3. Department of Pathology, Koshigaya Hospital, Dokkyo Medical University, Japan
Publisher
Japanese Society of Internal Medicine
Subject
General Medicine,Internal Medicine
Link
http://www.jstage.jst.go.jp/article/internalmedicine/50/18/50_18_1929/_pdf
Reference35 articles.
1. Cellular Protection by Erythropoietin: New Therapeutic Implications?
2. MULTIORGAN-PROTECTIVE ACTIONS OF BLOCKERS OF THE RENIN-ANGIOTENSIN SYSTEM, STATINS AND ERYTHROPOIETIN: COMMON PLEIOTROPIC EFFECTS IN RENO-, CARDIO- AND NEUROPROTECTION
3. Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner
4. Urinary L-Type Fatty Acid-Binding Protein Can Reflect Renal Tubulointerstitial Injury
5. Azelnidipine Reduces Urinary Protein Excretion and Urinary Liver-Type Fatty Acid Binding Protein in Patients with Hypertensive Chronic Kidney Disease
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metabolic Assessment in Non-Dialysis Patients with Chronic Kidney Disease;Journal of Inflammation Research;2024-08
2. Significance of Endothelial Dysfunction Amelioration for Sodium–Glucose Cotransporter 2 Inhibitor-Induced Improvements in Heart Failure and Chronic Kidney Disease in Diabetic Patients;Metabolites;2023-06-08
3. A Single Arm Clinical Study on the Effects of Continuous Erythropoietin Receptor Activator Treatment in Non-Dialysis Patients with Chronic Heart Failure and Renal Anemia;Biomedicines;2023-03-20
4. Early responsiveness to continuous erythropoietin receptor activator predicts renal prognosis and is determined by a novel antioxidative marker in non-dialysis chronic kidney disease: a prospective, observational, single-center study;Clinical and Experimental Nephrology;2020-03-17
5. Ascorbic acid lowers central blood pressure and asymmetric dimethylarginine in chronic kidney disease;Clinical Kidney Journal;2018-02-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3